Navigation Links
Now Single Jab Could Ward off Asthma, Eczema and Hay Fever

A Swiss firm has developed a vaccine that it says can ward off common allergies such as asthma, eczema and hay fever. //

The vaccine by Cytos Biotechnology has been tested on humans and contains harmless DNA similar to that found in the TB bug, reported the online edition of Daily Mail.

Rates of asthma have doubled in the past 20 years, with the condition affecting five million in England alone.

Figures for hay fever have also soared, with one in four suffering an allergy to pollen. Up to 2,400 children a year are taken to hospital with severe eczema, contributing to the health service's annual one billion pounds bill.

According to Muriel Simmons, chief executive of the charity Allergy UK, the new jab has the power to transform people's lives.

In a trial, 20 men and women with asthma and house dust mite allergy were given the vaccine once a week for six weeks. Eight months later, symptoms in 17 of the 20 had all but disappeared.

Tests showed they were at least 100 times more tolerant to dust mites than before.

"The results we have had look quite spectacular. We think this is a one size fits all treatment," Cytos chief executive Dr Wolfgang Renner said.

It is hoped the single jab with the power to protect against asthma, eczema and hay fever will be on sale by 2010.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Single gene analysis for diagnosis of a range of blood disorders
2. Single drug for bipolar disorder
3. Treating Testicular Cancer With A Single Dose Of Chemotherapy
4. Decreasing Multiple Births By Single Embryo Transfers
5. Single gene skin cancer cause
6. Drug Firms To Produce Single Pill AIDS Treatment
7. Malaria May Gain Resistance To Single Drug Prescriptions
8. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
9. Thai Doctors Removed 421 Kidney Stones From A Single Person
10. Single Dose Of Azithromycin Could Cure Trichiasis
11. Effects Of Certain Food Related To Single Pain Receptors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... San Rafael, CA (PRWEB) , ... May 26, ... ... Studio will be offering campers a multitude of activities from daily practices, arts ... and self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds ...
(Date:5/26/2016)... ... , ... Bunion Bootie , the manufacturer of the newest and best ... by customer demand over the Mother’s Day Weekend promotion. So much so, that they ... has completely replenished its inventory levels, it hopes to continue its current sales pace, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... organization to provide strategic sales leadership and to further develop their rapidly expanding ... B.S. in Business Administration with a concentration in Marketing and an M.B.A. with ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... announce the launch of its brand equity product, Brandvantage. This breakthrough tool ... dynamic landscape of modern consumer decision-making. The proprietary framework incorporates attitudes, behavior ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... announce that it has successfully completed another Health Canada inspection and has received ... Canada. The rating resulted from a Good Manufacturing Practices (GMP) inspection conducted at ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 According to ... Development, Growth and Demand Forecast to 2022 - Industry ... and Others)" published by P&S Market Research, the global ... in 2015, and it is expected to grow at ... the insulin pump segment is expected to witness the ...
(Date:5/25/2016)... 25, 2016 Inivata, a ... of circulating tumour DNA (ctDNA) analysis to improve ... of Professor Clive Morris as Chief ... the clinical development programme, scientific collaborations, and through ... significant improvements in clinical outcomes for patients. ...
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
Breaking Medicine Technology: